SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,842 | -25.1% | 11,770 | +0.3% | 0.00% | – |
| Q2 2023 | $54,555 | +14.3% | 11,732 | +13.6% | 0.00% | – |
| Q1 2023 | $47,725 | -49.5% | 10,330 | -11.6% | 0.00% | – |
| Q4 2022 | $94,455 | -10.0% | 11,690 | -9.6% | 0.00% | – |
| Q1 2022 | $105,000 | -55.9% | 12,929 | -19.1% | 0.00% | – |
| Q4 2021 | $238,000 | -18.2% | 15,990 | +3.7% | 0.00% | -100.0% |
| Q3 2021 | $291,000 | -19.8% | 15,414 | -21.0% | 0.00% | 0.0% |
| Q2 2021 | $363,000 | +7.1% | 19,522 | +30.9% | 0.00% | 0.0% |
| Q1 2021 | $339,000 | +28.9% | 14,911 | +22.9% | 0.00% | 0.0% |
| Q4 2020 | $263,000 | – | 12,137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |